Disease Prevention Related News

Oxitec to Build State-of-the-Art Mosquito Egg Production Unit

UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendly™ Aedes Mosquito Eggs per Week OXFORD, UK September, 19, 2017 – Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON), today announced plans to [...]

By | September 21st, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Evolva awarded contract by US government to advance novel pest control product

11 September 2017 – Evolva announced today that it has finalized negotiations for a contract with the US government. The key objective of this contract is to advance the development of safe, effective, and sustainably sourced next-generation products that can provide a [...]

By | September 12th, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Nothing to hide: An interview with Hadyn Parry

I remember sitting in a classroom during a summer course on synthetic biology and questioning just how much of this was science fiction and how much was interesting research that would never make it out of Nature (the journal) and [...]

By | September 12th, 2017|Agriculture, BioPharma & Healthcare, Crop Protection, Disease Prevention, News|

Oxitec’s Friendly™ Aedes Mosquito Receives Positive Evaluation for European Standard in relation to Human Health and the Environment

OXFORD, England, July 6, 2017 /PRNewswire/ -- The National Institute of Public Health and the Environment (RIVM) in the Netherlands today published its "Technical evaluation of a potential release of OX513A Aedes aegypti mosquitoes on the island of Saba", which positively concludes a vector [...]

By | July 10th, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|

Digital-to-Biological Converter for On-Demand Production of Biologics Developed by Synthetic Genomics, Inc.

SAN DIEGO, May 29, 2017 — Synthetic Genomics, Inc. announced today the publication of a peer reviewed article describing the development and operation of its digital-to-biological converter (DBC) prototype that produced biologic compounds on-demand without any human intervention. The DBC [...]

Oxitec’s Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project

Piracicaba, March 30th, 2017 - Oxitec and Piracicaba City Hall announced today new results from the Friendly™ Aedes project in the CECAP/Eldorado district and the first results in the São Judas neighborhood in the city’s central region. In CECAP/Eldorado, Friendly™ [...]

By | April 2nd, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|